174 related articles for article (PubMed ID: 33214178)
1. Imaging Artifacts of Liquid Embolic Agents on Conventional CT in an Experimental in Vitro Model.
Schmitt N; Floca RO; Paech D; El Shafie RA; Seker F; Bendszus M; Möhlenbruch MA; Vollherbst DF
AJNR Am J Neuroradiol; 2021 Jan; 42(1):126-131. PubMed ID: 33214178
[TBL] [Abstract][Full Text] [Related]
2. Imaging Artifacts of Nonadhesive Liquid Embolic Agents in Conventional and Cone-beam CT in a Novel in Vitro AVM Model.
Schmitt N; Floca RO; Paech D; El Shafie RA; Neuberger U; Bendszus M; Möhlenbruch MA; Vollherbst DF
Clin Neuroradiol; 2021 Dec; 31(4):1141-1148. PubMed ID: 33852036
[TBL] [Abstract][Full Text] [Related]
3. Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model.
Vollherbst DF; Otto R; Do T; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
Interv Neuroradiol; 2018 Dec; 24(6):693-701. PubMed ID: 29973083
[TBL] [Abstract][Full Text] [Related]
4. Beam hardening artifacts of liquid embolic agents: comparison between Squid and Onyx.
Pop R; Mertz L; Ilyes A; Mihoc D; Richter JS; Manisor M; Kremer S; Beaujeux R
J Neurointerv Surg; 2019 Jul; 11(7):706-709. PubMed ID: 30567844
[TBL] [Abstract][Full Text] [Related]
5. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas.
Vollherbst DF; Chapot R; Bendszus M; Möhlenbruch MA
Clin Neuroradiol; 2022 Mar; 32(1):25-38. PubMed ID: 34324005
[TBL] [Abstract][Full Text] [Related]
6. Visibility of liquid embolic agents in fluoroscopy: a systematic in vitro study.
Schmitt N; Wucherpfennig L; Hohenstatt S; Weyland CS; Sommer CM; Bendszus M; Möhlenbruch MA; Vollherbst DF
J Neurointerv Surg; 2023 Jun; 15(6):594-599. PubMed ID: 35508379
[TBL] [Abstract][Full Text] [Related]
7. Material-Specific Roadmap Modes Can Improve the Visibility of Liquid Embolic Agents for Endovascular Embolization: A Systematic In Vitro Study.
Schmitt N; Wucherpfennig L; Hohenstatt S; Karimian-Jazi K; Breckwoldt MO; Kauczor HU; Bendszus M; Möhlenbruch MA; Vollherbst DF
AJNR Am J Neuroradiol; 2022 Dec; 43(12):1749-1755. PubMed ID: 36357152
[TBL] [Abstract][Full Text] [Related]
8. Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.
Vollherbst DF; Sommer CM; Ulfert C; Pfaff J; Bendszus M; Möhlenbruch MA
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1377-1382. PubMed ID: 28522669
[TBL] [Abstract][Full Text] [Related]
9. Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.
Lamin S; Chew HS; Chavda S; Thomas A; Piano M; Quilici L; Pero G; Holtmannspolter M; Cronqvist ME; Casasco A; Guimaraens L; Paul L; Gil Garcia A; Aleu A; Chapot R
AJNR Am J Neuroradiol; 2017 Jan; 38(1):127-131. PubMed ID: 27932510
[TBL] [Abstract][Full Text] [Related]
10. Quantification of tantalum sedimentation rates in liquid embolic agents.
Mason JR; Dodge C; Benndorf G
Interv Neuroradiol; 2018 Oct; 24(5):574-579. PubMed ID: 29781371
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a New Version of the Liquid Embolic Agent PHIL with Extra-Low-Viscosity in an Endovascular Embolization Model.
Vollherbst DF; Otto R; Hantz M; Ulfert C; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1696-1702. PubMed ID: 30093480
[TBL] [Abstract][Full Text] [Related]
12. Embolization of peripheral arteriovenous malformations and fistulas with precipitating hydrophobic injectable liquid (PHIL
Giurazza F; Corvino F; Silvestre M; Cangiano G; De Magistris G; Cavaglià E; Amodio F; Niola R
Radiol Med; 2021 Mar; 126(3):474-483. PubMed ID: 32889705
[TBL] [Abstract][Full Text] [Related]
13. The impact of software-based metal artifact reduction on the liquid embolic agent Onyx in cone-beam CT: a systematic in vitro and in vivo study.
Schmitt N; Weyland CS; Wucherpfennig L; Sommer CM; Bendszus M; Möhlenbruch MA; Vollherbst DF
J Neurointerv Surg; 2022 Aug; 14(8):832-836. PubMed ID: 34433643
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.
Vollherbst DF; Otto R; von Deimling A; Pfaff J; Ulfert C; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
J Neurointerv Surg; 2018 Mar; 10(3):268-274. PubMed ID: 28689184
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations.
Koçer N; Hanımoğlu H; Batur Ş; Kandemirli SG; Kızılkılıç O; Sanus Z; Öz B; Işlak C; Kaynar MY
Diagn Interv Radiol; 2016; 22(2):184-9. PubMed ID: 26782157
[TBL] [Abstract][Full Text] [Related]
16. Iterative Metal Artifact Reduction (iMAR) of the Non-adhesive Liquid Embolic Agent Onyx in Computed Tomography : An Experimental Study.
Schmitt N; Weyland CS; Wucherpfennig L; Herweh C; Bendszus M; Möhlenbruch MA; Vollherbst DF
Clin Neuroradiol; 2022 Sep; 32(3):695-703. PubMed ID: 34643742
[TBL] [Abstract][Full Text] [Related]
17. Intermixed Dimethyl-Sulfoxide-Based Nonadhesive Liquid Embolic Agents Delivered Serially via the Same Microcatheter for Cerebral AVM Treatment.
Sirakov A; Minkin K; Sirakov S
AJNR Am J Neuroradiol; 2020 Apr; 41(4):681-686. PubMed ID: 32165357
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of the new PHIL low viscosity in a swine rete mirabile model.
Samaniego EA; Derdeyn CP; Hayakawa M; Hasan D; Ortega-Gutierrez S
Interv Neuroradiol; 2018 Dec; 24(6):706-712. PubMed ID: 29973081
[TBL] [Abstract][Full Text] [Related]
19. Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note.
Leyon JJ; Chavda S; Thomas A; Lamin S
J Neurointerv Surg; 2016 Jun; 8(6):596-602. PubMed ID: 25994938
[TBL] [Abstract][Full Text] [Related]
20. PHIL and Squid Embolization of Cerebral Arteriovenous Malformation: A Retrospective Case Series of 23 Patients.
Cheung EYH; Ng RYT; Yu SCH; Zhuang JTF; Wong GKC
Neurointervention; 2022 Nov; 17(3):174-182. PubMed ID: 36039561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
